search
Back to results

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial (OCTAVIA)

Primary Purpose

Acute Myocardial Infarction

Status
Completed
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Primary PCI
Sponsored by
Italian Society of Invasive Cardiology
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Acute Myocardial Infarction focused on measuring ST segment Elevation Myocardial Infarction, Optical Coherence Tomography, Percutaneous Coronary Intervention, Thrombus hystopathology, Gender differences

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acute Myocardial MI with ST segment Elevation, within 6 hours from symptoms onset
  • Native coronary artery disease (no prior stent implant, no prior brachytherapy)
  • Signed patient informed consent

Exclusion Criteria:

  • Patients with left main disease
  • infarct lesions in bypass grafts
  • cardiogenic shock
  • renal failure
  • recent major bleeding
  • allergy to aspirin or clopidogrel
  • on anticoagulant therapy
  • no suitable anatomy for OCT (extreme tortuousity, very distal culprit lesion, and large infarct vessel > 4 mm in diameter)

Sites / Locations

  • Ospedale Cardinal Massai
  • Ospedali Riuniti di Bergamo
  • Policlinico S.Orsola- Malpighi
  • Ospedale Ferrarotto
  • Ospedale S. Anna
  • USL 9 Grosseto
  • Policlinico Padova
  • Policlinico Parma
  • Policlinico Le Scotte
  • Ospedale San Giovanni Bosco
  • Ospedale Le Molinette
  • Ospedale Mauriziano
  • Ospedale Civile
  • Policlinico Gemelli

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Female Arm

Male Arm

Arm Description

Female gender diagnosed with ST segment Elevation Myocardial Infarction (STEMI)

Male Gender diagnosed with ST segment Elevation Acute Myocardial Infarction (STEMI)

Outcomes

Primary Outcome Measures

Percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT before PCI
To assess gender differences in the percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT. The OCT measurement is taken before stenting, when a TIMI flow 2-3 is detected. If baseline flow is TIMI 1, thrombus aspiration is performed before OCT.
Percent of covered stent struts by OCT in infarct-related lesion at 9 months (co-primary endpoint).
To assess gender differences in the percentage of covered stent struts at infarct related lesion as assessed by OCT performed in all patients at 9 months.

Secondary Outcome Measures

Minimal Fibrous Cap Thickness (MFCA) (µm) at infarct-related lesion as determined by OCT.
To assess gender differences in Minimal Fibrous Cap Thickness at infart related lesion by OCT immediataly after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation. The evolution of fibrous cap thickness over time will be determined by OCT that will be performed in all patients at 9 months from the index procedure.
Presence and type of residual thrombus material in the culprit vessel.
To assess gender differences in thrombus type by OCT in culprit vessel after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation.
Number of TCFA (<65 µM) as assessed by OCT in the culprit vessel (infarct related).
To assess gender difference in TCFA number as assessed by OCT in the infarct related vessel during the index procedure and at 9 months by OCT performed in all patients
percent of malapposed-uncovered struts
to assess gender difference in % malapposed/uncovered struts at 9 months follow up by OCT
percent net volume obstruction
To assess gender difference in % of stent volume obstruction by OCT at 9 months follow up
percent abnormal intraluminal tissue
To assess gender difference in % of abnormal intraluminal tissue by OCT at 9 months follow up

Full Information

First Posted
January 25, 2011
Last Updated
April 18, 2013
Sponsor
Italian Society of Invasive Cardiology
Collaborators
Meditrial SrL
search

1. Study Identification

Unique Protocol Identification Number
NCT01377207
Brief Title
Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial
Acronym
OCTAVIA
Official Title
Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2013
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
January 2013 (Actual)
Study Completion Date
April 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Italian Society of Invasive Cardiology
Collaborators
Meditrial SrL

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Recent studies suggest important gender differences in the pathophysiology and prognosis of ST-segment elevation myocardial infarction (STEMI). This is the first prospective controlled study to assess gender differences in the mechanism of plaque rupture/erosion and thrombus formation in patients presenting with STEMI treated with primary angioplasty. Gender-related mechanisms of plaque rupture or erosion will be investigated using a combination of Quantitative Coronary Angiography, high resolution Optical Coherence Tomography of the culprit vessel and histopathologic analyses of thrombus aspirates of the infarct related lesion, performed by independent core laboratories, blinded to group (male or female) and clinical variables.
Detailed Description
In OCTAVIA; enrollment in a 1:1 ratio according to gender group will be ensured by a computer-assisted matching algorithm for gender and age (< 50, 51-70, and > 70 years). Matching has the purpose to enable enrollment of an even number of male and female patients in balanced age groups. This type of dynamic algorithm is appropriate when the composition of the referral population is not known in advance. OCTAVIA will assess gender differences in the mechanism of plaque rupture. The study will also evaluate the changes in the vascular territory remote from the infarct related lesion, the local vascular response to primary angioplasty interventions and the correlation with clinical outcomes over one year of follow-up. These data are important to support a gender based differential strategy and can have a substantial impact for the improvement of clinical practice in the treatment of women with STEMI. The study sample of 140 patients is sized to address the hypothesis that the female population has a lower prevalence of plaque rupture (primary endpoint) at baseline OCT than the male population. Computations were conducted assuming a prevalence of rupture of 82% in males and 60% in female patients (22% lower). Confirmatory power calculation was performed on the basis of stent Strut Coverage at 9 month follow-up (co primary endpoint). Stent-strut coverage and apposition have been linked to the risk of stent thrombosis. However, our understanding of DES healing in male and female patients with ST-segment elevation myocardial infarction is restricted to post-mortem data. The investigators assumed a per patient stent strut coverage (a continuous variable with right skewed distribution) with mean of 97.0% and standard deviation of 4.0% in men, versus mean of 95.0% and standard deviation of 4.0% in women, following Xience Prime implantation. Thus, aiming for a 5% 2-tailed superiority alpha, an 80% power, and assuming a 1:1 enrollment according to gender, a total of 64 patients per group should be enrolled. Anticipating a 10% dropout rate due to patients lost to follow-up and inadequate imaging (included major side branch sections), the total enrollment is set at 70 patients per group (total population of 140 subjects).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction
Keywords
ST segment Elevation Myocardial Infarction, Optical Coherence Tomography, Percutaneous Coronary Intervention, Thrombus hystopathology, Gender differences

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
140 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Female Arm
Arm Type
Experimental
Arm Description
Female gender diagnosed with ST segment Elevation Myocardial Infarction (STEMI)
Arm Title
Male Arm
Arm Type
Active Comparator
Arm Description
Male Gender diagnosed with ST segment Elevation Acute Myocardial Infarction (STEMI)
Intervention Type
Procedure
Intervention Name(s)
Primary PCI
Intervention Description
Thrombus aspiration and hystopathological analysis, Optical Coherence Tomography assessment of STEMI culprit vessel, Primary PCI with Drug Eluting Stent implantation; Repeat OCT assessment of culprit vessel at 9 monts follow-up
Primary Outcome Measure Information:
Title
Percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT before PCI
Description
To assess gender differences in the percentage of ruptured or eroded plaques at infarct related lesion as assessed by OCT. The OCT measurement is taken before stenting, when a TIMI flow 2-3 is detected. If baseline flow is TIMI 1, thrombus aspiration is performed before OCT.
Time Frame
Plaque rupture is evaluated during the index PCI procedure.
Title
Percent of covered stent struts by OCT in infarct-related lesion at 9 months (co-primary endpoint).
Description
To assess gender differences in the percentage of covered stent struts at infarct related lesion as assessed by OCT performed in all patients at 9 months.
Time Frame
Stent coverage is evaluated at 9 months by OCT performed in all patients.
Secondary Outcome Measure Information:
Title
Minimal Fibrous Cap Thickness (MFCA) (µm) at infarct-related lesion as determined by OCT.
Description
To assess gender differences in Minimal Fibrous Cap Thickness at infart related lesion by OCT immediataly after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation. The evolution of fibrous cap thickness over time will be determined by OCT that will be performed in all patients at 9 months from the index procedure.
Time Frame
MFCA at index procedure (immediately after reestablishment of TIMI 2-3 coronary flow by PCI) and at 9 months OCT performed in all patients.
Title
Presence and type of residual thrombus material in the culprit vessel.
Description
To assess gender differences in thrombus type by OCT in culprit vessel after reestablishment of TIMI (Thrombolysis In Myocardial Infarction) 2-3 coronary blood flow and before stent implantation.
Time Frame
Residual thrombus in the infarct related vessel is evaluated during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow during primary percutaneous coronary intervention
Title
Number of TCFA (<65 µM) as assessed by OCT in the culprit vessel (infarct related).
Description
To assess gender difference in TCFA number as assessed by OCT in the infarct related vessel during the index procedure and at 9 months by OCT performed in all patients
Time Frame
Thin Fibrous Cap Atheroma is assessed during the index procedure: immediately after reestablishment of TIMI 2-3 coronary flow before stent implantationduring PCI; and at 9 months by OCT performed in all patients.
Title
percent of malapposed-uncovered struts
Description
to assess gender difference in % malapposed/uncovered struts at 9 months follow up by OCT
Time Frame
9 months
Title
percent net volume obstruction
Description
To assess gender difference in % of stent volume obstruction by OCT at 9 months follow up
Time Frame
9 months
Title
percent abnormal intraluminal tissue
Description
To assess gender difference in % of abnormal intraluminal tissue by OCT at 9 months follow up
Time Frame
9 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acute Myocardial MI with ST segment Elevation, within 6 hours from symptoms onset Native coronary artery disease (no prior stent implant, no prior brachytherapy) Signed patient informed consent Exclusion Criteria: Patients with left main disease infarct lesions in bypass grafts cardiogenic shock renal failure recent major bleeding allergy to aspirin or clopidogrel on anticoagulant therapy no suitable anatomy for OCT (extreme tortuousity, very distal culprit lesion, and large infarct vessel > 4 mm in diameter)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Giulio Guagliumi, MD
Organizational Affiliation
Italian Society of Invasive Cardiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ospedale Cardinal Massai
City
Asti
State/Province
AT
ZIP/Postal Code
14100
Country
Italy
Facility Name
Ospedali Riuniti di Bergamo
City
Bergamo
State/Province
BG
ZIP/Postal Code
24124
Country
Italy
Facility Name
Policlinico S.Orsola- Malpighi
City
Bologna
State/Province
BO
Country
Italy
Facility Name
Ospedale Ferrarotto
City
Catania
State/Province
CT
Country
Italy
Facility Name
Ospedale S. Anna
City
Ferrara
State/Province
FE
ZIP/Postal Code
44100
Country
Italy
Facility Name
USL 9 Grosseto
City
Grosseto
State/Province
GR
ZIP/Postal Code
48100
Country
Italy
Facility Name
Policlinico Padova
City
Padova
State/Province
PD
Country
Italy
Facility Name
Policlinico Parma
City
Parma
State/Province
PR
ZIP/Postal Code
43126
Country
Italy
Facility Name
Policlinico Le Scotte
City
Siena
State/Province
SI
ZIP/Postal Code
53100
Country
Italy
Facility Name
Ospedale San Giovanni Bosco
City
Torino
State/Province
TO
ZIP/Postal Code
10154
Country
Italy
Facility Name
Ospedale Le Molinette
City
Torino
State/Province
TO
Country
Italy
Facility Name
Ospedale Mauriziano
City
Torino
State/Province
TO
Country
Italy
Facility Name
Ospedale Civile
City
Mirano
State/Province
VE
Country
Italy
Facility Name
Policlinico Gemelli
City
Rome
ZIP/Postal Code
00168
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
25890582
Citation
Saia F, Komukai K, Capodanno D, Sirbu V, Musumeci G, Boccuzzi G, Tarantini G, Fineschi M, Tumminello G, Bernelli C, Niccoli G, Coccato M, Bordoni B, Bezerra H, Biondi-Zoccai G, Virmani R, Guagliumi G; OCTAVIA Investigators. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. JACC Cardiovasc Imaging. 2015 May;8(5):566-575. doi: 10.1016/j.jcmg.2015.01.018. Epub 2015 Apr 15.
Results Reference
derived
PubMed Identifier
25129664
Citation
Guagliumi G, Capodanno D, Saia F, Musumeci G, Tarantini G, Garbo R, Tumminello G, Sirbu V, Coccato M, Fineschi M, Trani C, De Benedictis M, Limbruno U, De Luca L, Niccoli G, Bezerra H, Ladich E, Costa M, Biondi Zoccai G, Virmani R; OCTAVIA Trial Investigators. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study. JACC Cardiovasc Interv. 2014 Sep;7(9):958-68. doi: 10.1016/j.jcin.2014.05.011. Epub 2014 Aug 13.
Results Reference
derived

Learn more about this trial

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial

We'll reach out to this number within 24 hrs